Literature DB >> 23993967

Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Wan Hua Tan1, Aleksander S Popel, Feilim Mac Gabhann.   

Abstract

Vascular Endothelial Growth Factor (VEGF) signal transduction is central to angiogenesis in development and in pathological conditions such as cancer, retinopathy and ischemic diseases. We constructed and validated a computational model of VEGFR2 trafficking and signaling, to study the role of receptor trafficking kinetics in modulating ERK phosphorylation in VEGF-stimulated endothelial cells. Trafficking parameters were optimized and validated against four previously published in vitro experiments. Based on these parameters, model simulations demonstrated interesting behaviors that may be highly relevant to understanding VEGF signaling in endothelial cells. First, at moderate VEGF doses, VEGFR2 phosphorylation and ERK phosphorylation are related in a log-linear fashion, with a stable duration of ERK activation; but with higher VEGF stimulation, phosphoERK becomes saturated, and its duration increases. Second, a large endosomal fraction of VEGFR2 makes the ERK activation reaction network less sensitive to perturbations in VEGF dosage. Third, extracellular-matrix-bound VEGF binds and activates VEGFR2, but by internalizing at a slower rate, matrix-bound VEGF-induced intracellular ERK phosphorylation is predicted to be greater in magnitude and more sustained, in agreement with experimental evidence. Fourth, different endothelial cell types appear to have different trafficking rates, which result in different levels of endosomal receptor localization and different ERK response profiles.
© 2013.

Entities:  

Keywords:  Angiogenesis; Endothelial signaling; Mathematical model; Receptor tyrosine kinase; Systems biology; Trafficking

Mesh:

Substances:

Year:  2013        PMID: 23993967      PMCID: PMC3865527          DOI: 10.1016/j.cellsig.2013.08.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  61 in total

Review 1.  An inside view: VEGF receptor trafficking and signaling.

Authors:  Michael Simons
Journal:  Physiology (Bethesda)       Date:  2012-08

2.  Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops.

Authors:  Anatoly Kiyatkin; Edita Aksamitiene; Nick I Markevich; Nikolay M Borisov; Jan B Hoek; Boris N Kholodenko
Journal:  J Biol Chem       Date:  2006-05-09       Impact factor: 5.157

Review 3.  Four-dimensional dynamics of MAPK information processing systems.

Authors:  Boris N Kholodenko; Marc R Birtwistle
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

4.  Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.

Authors:  Christine Caron; Kathleen Spring; Mélanie Laramée; Catherine Chabot; Monikca Cloutier; Haihua Gu; Isabelle Royal
Journal:  Cell Signal       Date:  2009-02-20       Impact factor: 4.315

5.  Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival.

Authors:  Yi Wang; Steven Pennock; Xinmei Chen; Zhixiang Wang
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

6.  Platelet-derived growth factor receptor-mediated signal transduction from endosomes.

Authors:  Yi Wang; Steven D Pennock; Xinmei Chen; Andrius Kazlauskas; Zhixiang Wang
Journal:  J Biol Chem       Date:  2003-12-02       Impact factor: 5.157

7.  Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation.

Authors:  Wan Hua Tan; Aleksander S Popel; Feilim Mac Gabhann
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

8.  The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling.

Authors:  Marianne O Stefanini; Florence T H Wu; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS Comput Biol       Date:  2009-12-24       Impact factor: 4.475

9.  VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.

Authors:  Z Zhang; K G Neiva; M W Lingen; L M Ellis; J E Nör
Journal:  Cell Death Differ       Date:  2009-10-16       Impact factor: 15.828

10.  Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses.

Authors:  Marc R Birtwistle; Mariko Hatakeyama; Noriko Yumoto; Babatunde A Ogunnaike; Jan B Hoek; Boris N Kholodenko
Journal:  Mol Syst Biol       Date:  2007-11-13       Impact factor: 11.429

View more
  19 in total

1.  Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.

Authors:  H N Ashiqur Rahman; Hao Wu; Yunzhou Dong; Satish Pasula; Aiyun Wen; Ye Sun; Megan L Brophy; Kandice L Tessneer; Xiaofeng Cai; John McManus; Baojun Chang; Sukyoung Kwak; Negar S Rahman; Wenjia Xu; Conrad Fernandes; John Michael Mcdaniel; Lijun Xia; Lois Smith; R Sathish Srinivasan; Hong Chen
Journal:  Circ Res       Date:  2016-02-15       Impact factor: 17.367

Review 2.  Systems biology of the microvasculature.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  Integr Biol (Camb)       Date:  2015-04-02       Impact factor: 2.192

3.  The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.

Authors:  Ding Li; Stacey D Finley
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

4.  Fibronectin fibrils regulate TGF-β1-induced Epithelial-Mesenchymal Transition.

Authors:  Lauren A Griggs; Nadiah T Hassan; Roshni S Malik; Brian P Griffin; Brittany A Martinez; Lynne W Elmore; Christopher A Lemmon
Journal:  Matrix Biol       Date:  2017-01-19       Impact factor: 11.583

Review 5.  Computational systems biology approaches to anti-angiogenic cancer therapeutics.

Authors:  Stacey D Finley; Liang-Hui Chu; Aleksander S Popel
Journal:  Drug Discov Today       Date:  2014-10-05       Impact factor: 7.851

6.  Quantitative insight in utilizing circulating angiogenic factors as biomarkers for antiangiogenic therapy: systems pharmacology approach.

Authors:  S Sharan; S Woo
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-10-08

7.  Site-Specific Phosphorylation of VEGFR2 Is Mediated by Receptor Trafficking: Insights from a Computational Model.

Authors:  Lindsay Wendel Clegg; Feilim Mac Gabhann
Journal:  PLoS Comput Biol       Date:  2015-06-12       Impact factor: 4.475

8.  Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.

Authors:  Satish Sharan; Sukyung Woo
Journal:  Front Pharmacol       Date:  2015-02-20       Impact factor: 5.810

9.  Quantitative characterization of cellular membrane-receptor heterogeneity through statistical and computational modeling.

Authors:  Jared C Weddell; P I Imoukhuede
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

10.  VEGF regulates local inhibitory complement proteins in the eye and kidney.

Authors:  Lindsay S Keir; Rachel Firth; Lyndsey Aponik; Daniel Feitelberg; Susumu Sakimoto; Edith Aguilar; Gavin I Welsh; Anna Richards; Yoshihiko Usui; Simon C Satchell; Valeryia Kuzmuk; Richard J Coward; Jonathan Goult; Katherine R Bull; Ruchi Sharma; Kapil Bharti; Peter D Westenskow; Iacovos P Michael; Moin A Saleem; Martin Friedlander
Journal:  J Clin Invest       Date:  2016-12-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.